Keyphrases
Aryl Hydrocarbon Receptor
100%
Dibenzo
64%
GPI-anchored Protein (GPI-AP)
43%
Chrysene
43%
Plasmodium Falciparum
42%
Ah Receptor
42%
DNA Damage
36%
Pyrene
26%
Maritoclax
25%
Myeloid Cell leukemia-1 (Mcl-1)
25%
Aldehyde Dehydrogenase 2 (ALDH2)
24%
Receptor Activation
24%
Black Raspberry
21%
Tobacco Carcinogens
20%
Environmental Pollutants
19%
Tobacco Smoke
19%
Aryl Hydrocarbon Receptor Activity
18%
Macrophages
17%
Inflammatory Response
17%
Oral Cavity
17%
Multiple Myeloma
17%
Polycyclic Aromatic Hydrocarbons
16%
Carcinogen
16%
Raspberry Extract
15%
DNA Adducts
15%
Smoke Constituents
14%
Apoptosis
14%
Induced Apoptosis
14%
Bruton's Tyrosine Kinase
13%
N-nitrosamines
13%
Diol Epoxide
13%
Mcl-1 Inhibitor
12%
Tryptophan Metabolites
12%
Verapamil
12%
Oral Tissues
12%
Benzo(a)pyrene
11%
Vinblastine
11%
In Cancer
11%
Mutagenesis
11%
Ligand-mediated
11%
Structural Requirements
11%
Receptor Antagonism
11%
Cancer Cells
10%
Keratinocytes
10%
Multidrug-resistant
10%
Pyridyl
10%
Fibroblast-like
10%
Resistant Cancer Cells
10%
Human Oral Cancer Cells
10%
High Risk
10%
Pharmacology, Toxicology and Pharmaceutical Science
Aromatic Hydrocarbon Receptor
87%
Chrysene
49%
Phosphorotrithioic Acid Tributyl Ester
49%
Malignant Neoplasm
47%
Carcinogen
44%
dibenzo[a,l]pyrene
25%
Aldehyde Dehydrogenase
22%
Raspberry
21%
Neoplasm
20%
Aldehyde Dehydrogenase Inhibitor
17%
Mutagenesis
16%
Carcinogenesis
15%
Epoxide
15%
Tryptophan
12%
Cytokine
12%
Vinblastine
12%
Breast Cancer
12%
Benzo(a)pyrene
12%
Isatin
12%
Leukoplakia
11%
Anticancer Drug
11%
Melanoma
10%
Papillomavirus Infection
10%
Casein Kinase
10%
Mouth Cancer
10%
Acridone Derivative
10%
Acute Myeloid Leukemia
10%
4 (Methylnitrosamino) 1 (3 Pyridyl) 1 Butanone
10%
Tobacco-Specific Nitrosamines
10%
Casein Kinase II
10%
Docosahexaenoic Acid
10%
Leukemia
10%
Dioxins and Dioxin-Like Compounds
9%
Biological Marker
9%
Oxygen
8%
Carcinogenicity
8%
Nicotine-Derived Nitrosamine Ketone
7%
Squamous Cell Carcinoma
7%
Receptor Antagonist
7%
N-Nitrosonornicotine
7%
Isatin Derivative
7%
Multiple Myeloma
6%
Drug Resistance
6%
Infection
6%
Inflammation
6%
Verapamil
6%
Thymidine
6%
Anti-Inflammatory Drug
6%